Crossmark

High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s12944-019-1005-8

Published Online: 2019-03-30

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gao, Bo

Xiao, Jiangqiang

Zhang, Ming

Zhang, Feng

Zhang, Wei

Yang, Jian

He, Jian

Liu, Yu

Zou, Xiaoping

Xu, Ping

Zhuge, Yuzheng http://orcid.org/0000-0002-0649-4457
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (AA803)

Natural Science Foundation of Jiangsu Province (KA1138)
License Information

Text and Data Mining valid from 2019-03-30
More Information

Article History

Received: 8 February 2019

Accepted: 5 March 2019

First Online: 30 March 2019

Ethics approval and consent to participate

: According to the principles of Declaration of Helsinki of 1975, the retrospective study was approved by the Clinical Research Ethics Committee of the Drum Tower Hospital. All participants were verbally informed about the study. Written informed consent was waived due to retrospective and observational nature of the study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.